Genenta Science SpA - ADR
GNTA
Get informed when a big investor buys or sells
+ FollowMarket Cap$28.72M
Close$
$-0.12
109.6% downside
Current Fair Value
109.6% downsideOvervalued by 109.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $28.72 Million |
|---|---|
| Enterprise Value | $30.80 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.33 |
| Beta | 0.75 |
| Outstanding Shares | 21,218,264 |
Return
| Return on Equity | -70.61% |
|---|---|
| Return on Assets | -48.36% |
| Return on Invested Capital | -54.90% |
Valuation & Multiples
| P/E Ratio | -3.98 |
|---|---|
| PEG | 8.86 |
| Price to Sales | - |
| Price to Book Ratio | 1.25 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.88 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 31, 2026
EPS Estimate
$-0.36
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.25%▼ 9.21% |
|---|---|
| Total Invested | $695,671▼ 82.80% |
| Investors Holding | 11▼ 4.00% |
ESG Score
No data